Aptose Biosciences Inc (APS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 05-2005 | 05-2004 | 05-2003 | 05-2002 | 05-2001 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,868 | 1,590 | 1,482 | 2,423 | 2,408 |
| Other Working Capital | -929 | -95 | 1,471 | -1,391 | 1,202 |
| Other Operating Activity | -15,858 | -22,093 | -11,628 | -8,825 | -9,894 |
| Operating Cash Flow | $-14,919 | $-20,598 | $-8,676 | $-7,793 | $-6,284 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -477 | -281 | 8,145 | -312 | -112 |
| Purchase Of Investment | N/A | -1,055 | N/A | N/A | -26,261 |
| Sale Of Investment | 5,558 | N/A | N/A | 6,137 | N/A |
| Other Investing Activity | 0 | -1 | -1 | 0 | 1 |
| Investing Cash Flow | $5,081 | $-1,337 | $8,144 | $5,825 | $-26,372 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 879 | 22,056 | 521 | 909 | 1,343 |
| Other Financing Activity | 10,318 | 0 | -178 | 0 | 0 |
| Financing Cash Flow | $11,197 | $22,056 | $343 | $909 | $1,343 |
| Beginning Cash Position | 854 | 665 | 849 | 1,821 | 33,124 |
| End Cash Position | 2,212 | 786 | 660 | 762 | 1,810 |
| Net Cash Flow | $1,359 | $121 | $-189 | $-1,060 | $-31,313 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,919 | -20,598 | -8,676 | -7,793 | -6,284 |
| Capital Expenditure | -477 | -281 | -918 | -312 | -112 |
| Free Cash Flow | -15,396 | -20,879 | -9,593 | -8,105 | -6,396 |